NY TIMES Op-Ed Piece: Jurors Need to Know That They Can Say No

Here’s a wonderful piece by Paul Butler from the New York Times about your constitutional right to Jury Nullification. Remember that we, the People, still have rights when it comes to deciding what is fair and have the chance to be heard loud and clear.

“IF you are ever on a jury in a marijuana case, I recommend that you vote “not guilty” — even if you think the defendant actually smoked pot, or sold it to another consenting adult. As a juror, you have this power under the Bill of Rights; if you exercise it, you become part of a proud tradition of American jurors who helped make our laws fairer.

The information I have just provided — about a constitutional doctrine called “jury nullification” — is absolutely true. But if federal prosecutors in New York get their way, telling the truth to potential jurors could result in a six-month prison sentence.

Earlier this year, prosecutors charged Julian P. Heicklen, a retired chemistry professor, with jury tampering because he stood outside the federal courthouse in Manhattan providing information about jury nullification to passers-by. Given that I have been recommending nullification for nonviolent drug cases since 1995 — in such forums as The Yale Law Journal, “60 Minutes” and YouTube — I guess I, too, have committed a crime.

The prosecutors who charged Mr. Heicklen said that “advocacy of jury nullification, directed as it is to jurors, would be both criminal and without constitutional protections no matter where it occurred.” The prosecutors in this case are wrong. The First Amendment exists to protect speech like this — honest information that the government prefers citizens not know.

Laws against jury tampering are intended to deter people from threatening or intimidating jurors. To contort these laws to justify punishing Mr. Heicklen, whose court-appointed counsel describe him as “a shabby old man distributing his silly leaflets from the sidewalk outside a courthouse,” is not only unconstitutional but unpatriotic. Jury nullification is not new; its proponents have included John Hancock and John Adams.

The doctrine is premised on the idea that ordinary citizens, not government officials, should have the final say as to whether a person should be punished. As Adams put it, it is each juror’s “duty” to vote based on his or her “own best understanding, judgment and conscience, though in direct opposition to the direction of the court.”

In 1895, the Supreme Court ruled that jurors had no right, during trials, to be told about nullification. The court did not say that jurors didn’t have the power, or that they couldn’t be told about it, but only that judges were not required to instruct them on it during a trial. Since then, it’s been up to scholars like me, and activists like Mr. Heicklen, to get the word out.

Nullification has been credited with helping to end alcohol prohibition and laws that criminalized gay sex. Last year, Montana prosecutors were forced to offer a defendant in a marijuana case a favorable plea bargain after so many potential jurors said they would nullify that the judge didn’t think he could find enough jurors to hear the case. (Prosecutors now say they will remember the actions of those jurors when they consider whether to charge other people with marijuana crimes.)

There have been unfortunate instances of nullification. Racist juries in the South, for example, refused to convict people who committed violent acts against civil-rights activists, and nullification has been used in cases involving the use of excessive force by the police. But nullification is like any other democratic power; some people may try to misuse it, but that does not mean it should be taken away from everyone else.

How one feels about jury nullification ultimately depends on how much confidence one has in the jury system. Based on my experience, I trust jurors a lot. I first became interested in nullification when I prosecuted low-level drug crimes in Washington in 1990. Jurors here, who were predominantly African-American, nullified regularly because they were concerned about racially selective enforcement of the law.

Across the country, crime has fallen, but incarceration rates remain at near record levels. Last year, the New York City police made 50,000 arrests just for marijuana possession. Because prosecutors have discretion over whether to charge a suspect, and for what offense, they have more power than judges over the outcome of a case. They tend to throw the book at defendants, to compel them to plead guilty in return for less harsh sentences. In some jurisdictions, like Washington, prosecutors have responded to jurors who are fed up with their draconian tactics by lobbying lawmakers to take away the right to a jury trial in drug cases. That is precisely the kind of power grab that the Constitution’s framers were so concerned about.

In October, the Supreme Court justice Antonin Scalia, asked at a Senate hearing about the role of juries in checking governmental power, seemed open to the notion that jurors “can ignore the law” if the law “is producing a terrible result.” He added: “I’m a big fan of the jury.” I’m a big fan, too. I would respectfully suggest that if the prosecutors in New York bring fair cases, they won’t have to worry about jury nullification. Dropping the case against Mr. Heicklen would let citizens know that they are as committed to justice, and to free speech, as they are to locking people up.”

Paul Butler, a former federal prosecutor, is a professor of law at George Washington University and the author of “Let’s Get Free: A Hip-Hop Theory of Justice.”

TX NORML Sign

Puff, puff, pass...
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • email
  • MySpace
  • Reddit
  • StumbleUpon
  • TwitThis
  • Twitter
  • Tumblr
  • Add to favorites

21

12 2011

NORML News of the Week 12/15/2011

norml logo

From NORML.org:

Study: Inhaled Cannabis Modulates Appetite Hormones In HIV Patients
‘False Alert’ Rate For Drug Dogs Tops 80 Percent
House Lawmakers Vote In Favor Of Federal Legislation Outlawing So-Called ‘Synthetic Cannabis’

Recent Action Alerts:
Wisconsin Legislature to Consider Medical Marijuana Measure
Tell The Obama Administration to Halt Its Attack on Medical Marijuana
Tell Your Representatives to Co-Sponsor HR 2306: The Ending Federal Marijuana Prohibition Act of 2011

Study: Inhaled Cannabis Modulates Appetite Hormones In HIV Patients

San Diego, CA: Cannabis inhalation is associated with increased levels of appetite hormones in the blood of subjects with HIV infection, according to clinical trial data published online in the scientific journal Brain Research.

Investigators at the University of California, San Diego and the Center for Medicinal Cannabis Research assessed the effects of inhaled cannabis on the appetite hormones ghrelin, leptin and peptide YY (PYY), as well as insulin, in adult subjects with HIV.

Insulin, ghrelin, PYY, and leptin are hormones individually modulated in response to food intake and energy homeostasis.

Researchers reported: “Compared to placebo, cannabis administration was associated with significant increases in plasma levels of ghrelin and leptin, and decreases in PYY, but did not significantly influence insulin levels. … Cannabis-related changes in these hormones had a magnitude similar to what has been observed with food intake over the course of a day in normal volunteers, suggesting physiological relevance.”

They concluded, “These findings support further evaluations of interventions directed at manipulating the endocannabinoid system for the treatment of eating disorders and obesity.”

For more information, please contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men,” appears in Brain Research.

‘False Alert’ Rate For Drug Dogs Tops 80 Percent

Sydney, Australia: Some 80 percent of drug dog ‘alerts’ in New South Wales in 2011 yielded no illicit substances, according to state government statistics published this week by the Sydney Morning Herald.

According to the paper, in the first nine months of 2011, “14,102 searches were conducted after a dog sat next to a person, indicating they might be carrying drugs. But, in 11,248 cases, no drugs were found.”

Statistics for 2010 showed a similarly high false positive rate. Of the 15,779 searches conducted after police-dog identification, no drugs were found in 11,694 cases, the Herald reported.

The statistics were made public following a Parliamentary inquiry regarding the widespread use of drug dogs.

Despite the high error rate, a spokesman for the NSW Police Minister said that the government “fully supported the use of dogs because police had found them effective.”

Earlier this year, a study published in the scientific journal Animal Cognition reported that the performance of drug-sniffing dogs is significantly influenced by whether or not their handlers believe illicit substances are present.

In 2004, the United States Supreme Court ruled in Illinois v. Caballes that an alert from a police dog during a traffic stop provides a constitutional basis for law enforcement to search the interior of the vehicle.

For more information, please contact Keith Stroup, NORML Legal Counsel, at (202) 483-5500.

House Lawmakers Vote In Favor Of Federal Legislation Outlawing So-Called ‘Synthetic Cannabis’

Washington, DC: Members of the US Congress, House of Representatives voted 317 to 98 last week in support of HR 1254, the Synthetic Drug Control Act. The act criminalizes the possession or use of “any substance that is a cannabinoid receptor type 1 agonist” by classifying all such substances as Schedule I prohibited drugs under federal law “unless [the substance is] specifically exempted or … listed in another schedule.”

If passed, the measure would prohibit under federal law the possession and sale of chemical agents contained in so-called ‘fake’ herbal marijuana products, commonly sold over-the-counter under the brand names ‘K2′ and ‘Spice.’

The measure now awaits action in the Senate.

Senate companion legislation, S. 605, also remains pending.

In March, the US Drug Enforcement Administration (DEA) exercised its ‘emergency scheduling authority’ to criminally prohibit the possession and sale of several of the synthetic cannabinoids contained in over-the-counter products such as Spice.

Commenting on the Congressional vote, NORML Deputy Director Paul Armentano said, “The growing popularity of these synthetic cannabinoid products is a predictable outgrowth of criminal marijuana prohibition. As prohibition is apt to do, it has driven the production of a commodity into the hands of unregulated, unknown dealers, driven up the potency of the commodity, and in doing so created a scenario where the consumer is faced with a potentially greater health risks than they would be had they simply had the legal choice to use the product they actually desired, in this case cannabis.”

He added, “No doubt the consumption of some of these unregulated products may pose risks to the consumer. However, it is hard to fathom that these potential risks will be lessened by further driving the products underground as opposed to regulating thereby allowing for the opportunity for quality control, laboratory testing, labeling, and human trials.”

For more information, please contact Paul Armentano, NORML Deputy Director, at: paul@norml.org or Keith Stroup, NORML Legal Counsel, at (202) 483-5500.

NORML and the NORML Foundation: 1600 K Street NW, Mezzanine Level, Washington DC, 20006-2832
Tel: (202) 483-5500 • Fax: (202) 483-0057 • Email: norml@norml.org

TX NORML Sign

Puff, puff, pass...
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • email
  • MySpace
  • Reddit
  • StumbleUpon
  • TwitThis
  • Twitter
  • Tumblr
  • Add to favorites

15

12 2011

My Fox Austin:”Suicide Disease” Causes Intense Pain

Good Morning all,

My Fox Austin recently did a profile on Texas NORML member Joseph Kenyon. Joseph suffers from a condition called Trigeminal Neuralgia, a nerve disorder also known as the “Suicide Disease”. Check out his story from myfoxaustin.com and head on over to their page to leave a comment on the story to help raise awareness of this condition and Joseph’s fight to medicate how he chooses.

“Suicide Disease” Causes Intense Pain: MyFoxAUSTIN.com

“Austin, (TX) – According to sufferers of Trigeminal Neuralgia or TN the pain is like being struck by lightning or a sudden stab to the face.

The excruciating pain is so bad many call it “the suicide disease” because it has sufferers taking their own lives.

The affliction is a hard one for doctors to diagnose. At first people think the pain could be just a toothache. However, when they realize the pain doesn’t go away after seeing the dentist, they find out they have TN.
Everyday Joseph Kenyon, a former artist who suffers from TN, feels pain.

“If it gets much worse I’m going to have to call off the interview,” said Kenyon.

“Right now it’s feeling like someone is taking a nail into the back of my eye,” he told FOX 7.

For the past six years Kenyon has dealt with sleepless nights and numerous days stuck in bed. The condition is something that Kenyon says just happens.

“I was walking from the living room to the bathroom and all of a sudden it just felt like someone shot me in the face it felt like something sharp. It hurt so bad it dropped me to my knees,” said Kenyon.
Doctor Michael Webb with the NeuroTexas Institute says this condition is usually seen in people 40 to 70 years old and is pretty rare.

“Sometimes as you get older your blood vessels become more firm and they can move a little bit and press against the trigeminal nerve,” said Webb.

Symptoms are usually pain in the lower half of your face typically on one side, the pain comes and goes and can be triggered by talking, chewing or even brushing your teeth.

Doctor Webb says TN is often caused by blood vessels compressing against the trigeminal nerve.
Kenyon has tried everything and anything to suppress the pain – from opioids to even an illegal drug.

“Marijuana stopped it. It stopped the spasms it doesn’t stop the pain completely. It gave me a feeling of relaxation,” said Kenyon.

Besides drugs, Kenyon tried a popular treatment for TN called Microvascular Decompression, a treatment that can drive the pain away for years.

In Kenyon’s case the pain came back months later.

“For a lack of a better word it’s electrifying it’s like zzz almost like a bubbling sensation,” said Kenyon.

Now Kenyon is hoping for a cure because the last thing he wants to do is live up to the name suicide disease.

“The sensations will pass hopefully, eventually you can’t give into them,” said Kenyon.

Every year – there are 14,000 new cases of TN in the United States. There are an estimated 140,000 with the condition right now. More women are diagnosed with the condition.

It’s also common for people who suffer from multiple sclerosis to develop trigeminal neuralgia.
According to the National Pain Foundation, TN is one of the most painful disorders known.”

TX NORML Sign

Puff, puff, pass...
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • email
  • MySpace
  • Reddit
  • StumbleUpon
  • TwitThis
  • Twitter
  • Tumblr
  • Add to favorites

12

12 2011

NORML News of the Week 12/8/2011

norml logo

From NORML.org:

New York City Finally Sees Reduction in Marijuana Arrests
Bi-Partisan Group of Governors Call on President Obama to Re-Schedule Marijuana
Keep NORML In Mind for End-of-Year Charitable Giving

Recent Action Alerts:

Wisconsin Legislature to Consider Medical Marijuana Measure
Tell The Obama Administration to Halt Its Attack on Medical Marijuana
Tell Your Representatives to Co-Sponsor HR 2306: The Ending Federal Marijuana Prohibition Act of 2011

New York City Finally Sees Reduction in Marijuana Arrests

New York, NY: The shift away from arresting minor marijuana offenders in New York City, announced as a “clarification” on September 19, 2011 by New York Police Commissioner Raymond Kelly, appears to be having the desired effect. Prior to the announcement, city police were regularly arresting those with small amounts of marijuana in their possession, although state law defines the private possession of less than an ounce of marijuana is a $100 civil fine. But smoking in public or possessing it publicly remains a misdemeanor with a possible 3 months in jail and a $500 fine.

Figures released by the New York Division of Criminal Justice Services show that in 2010, the New York City Police Department arrested 50,383 people for low-level marijuana offenses. Arrests for low-level marijuana possession offenses are the number one arrest in New York City, making up 15 percent of all arrests. On average, nearly 140 people are arrested every day for marijuana possession in NYC, making the Big Apple the “Marijuana Arrest Capital of the World.”

Arrests for low-level marijuana possession fell 13% in the city in the weeks after the police commissioner cautioned officers not to bust people for small amounts of the drug found in pockets or bags, according to department data released Wednesday. Department figures show 1,190 fewer arrests were made in the nine weeks since the order, compared with the same period a year earlier.

More than 85 percent of those arrested for marijuana in New York City are blacks and Latinos in the poorest neighborhoods where the highest rates of stop-and-frisk occur, despite usage rates among the three groups being essentially the same.

For more information, please contact Allen St. Pierre, NORML Executive Director, at (202) 483-5500.

Bi-Partisan Group of Governors Call on President Obama to Re-Schedule Marijuana

Olympia, WA: A number of governors from states that have legalized the medical use of marijuana are calling on President Obama to reschedule marijuana federally, to avoid the current conflict with state and federal law.

Independent Governor Lincoln Chafee of Rhode Island, Democrat Governors Christine Gregoire of Washington, and Peter Shumlin of Vermont have petitioned the federal government to reschedule marijuana under the federal Controlled Substances Act from Schedule I to Schedule II, which would permit the drug to be prescribed by physicians as a medicine.

“What we have here on the ground is chaos,” said Governor Gregoire., adding that patients “who … either feel like they’re criminals or may be engaged in some criminal activity, and really are legitimate patients who want medical marijuana.”

Connecticut Democrat Governor Daniel Malloy has said he will also be joining the group of governors petitioning the federal government.

Democrat Governor John Hickenlooper of Colorado has announced that he will be making a similar request to the Obama administration prior to January 1, 2012, as required by state law.

Rescheduling marijuana to a lower schedule under federal law would not authorize medical marijuana dispensaries, such as those that exist under state law in California, Colorado, New Mexico and Maine, and that have been authorized in a handful of additional states, but it would begin the process of making marijuana available from licensed pharmacists.

For more information, please contact NORML Legal Counsel Keith Stroup at keith@norml.org.
.
Keep NORML In Mind for End-of-Year Charitable Giving

Washington, DC: As we approach the end of the year, most Americans give some consideration to making charitable contributions to help others, contributions that can be taken as a tax deduction on one’s 2011 federal and state tax returns.

Donations to the NORML Foundation, a 501(c3) educational foundation, fully qualify for a tax-deductible charitable contribution. The Foundation was established in 1997 to better educate the public about marijuana and marijuana policy options, and to assist victims of the current laws.

“For four decades NORML and the NORML Foundation have relied on contributions from supportive individuals to fund our work, and that support is especially important as we head into the New Year,” said NORML and NORML foundation Executive Director Allen St. Pierre. “I urge those who support the full legalization of marijuana for adults, regardless of why they smoke, to make a generous end-of-the-year donation today to the NORML Foundation.”

Donations of appreciated stock can maximize one’s giving and tax-planning efficiency.

Contributions can be made online at the following location:

http://norml.org/join-norml/tax-deductible-norml-foundation

To make a major gift of cash, stocks or in-kind donations of goods or services (i.e., a retailer who is a NORML supporter just donated 1,000 odorless backpacks to the organization for fundraising!), please contact NORML’s executive director Allen St. Pierre at 202-483-5500 or director@norml.org

NORML and the NORML Foundation: 1600 K Street NW, Mezzanine Level, Washington DC, 20006-2832
Tel: (202) 483-5500 • Fax: (202) 483-0057 • Email: norml@norml.org

TX NORML Sign

Puff, puff, pass...
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • email
  • MySpace
  • Reddit
  • StumbleUpon
  • TwitThis
  • Twitter
  • Tumblr
  • Add to favorites

09

12 2011

NORML News of the Week 12/1/2011

norml logo

From NORML.org:
Cannabis Beneficial To Patients With Inflammatory Bowel Disease
Prescription Drug Efavirenz Yields False Positive Test Results For THC, Study Says
Hospice Health Professionals Support Legalization Of Cannabis For Therapeutic Use

Recent Action Alerts:

Tell The Obama Administration to Halt Its Attack on Medical Marijuana
Tell Your Representatives to Co-Sponsor HR 2306: The Ending Federal Marijuana Prohibition Act of 2011
Massachusetts Legislature Considers Medical Marijuana Measure

Cannabis Beneficial To Patients With Inflammatory Bowel Disease

“Inhaled cannabis improves quality of life measurements, disease activity index, and causes weight gain”

Tel Aviv, Israel: The inhalation of cannabis increases quality of life, mitigates disease activity, and promotes weight gain in subjects with inflammatory bowel disease (IBD), according to clinical trial data published online in the scientific journal Digestion.

Investigators at the Chaim Sheba Medical Center in Tel Aviv, Israel assessed the efficacy of inhaled prescription cannabis in patients with long-standing IBD, such as Crohn’s disease.

Researchers reported: “After three months’ treatment, patients reported improvement in general health perception, social functioning, ability to work, physical pain and depression. A schematic scale of health perception showed an improved score. … Patients had … weight gain … during treatment and an average rise in BMI (body mass index).”

They concluded, “Three months’ treatment with inhaled cannabis improves quality of life measurements, disease activity index, and causes weight gain and rise in BMI in long-standing IBD patients.”

An estimated 6,000 Israelis are supplied with locally grown cannabis for therapeutic purposes as part of a limited government program.

Survey data published in August in the European Journal of Gastroenterology and Hepatology reported that an estimated one-third of patients with colitis and one-half of subjects with Crohn’s acknowledge having used cannabis to mitigate their disease symptoms.

Most recently, clinical trial data published in September in the Journal of the Israeli Medical Association reported that the use of cannabis is associated with a reduction in Crohn’s disease activity and disease-related surgeries.

Researchers at the Meir Medical Center in Israel are presently evaluating the safety and efficacy of inhaled cannabis for patients with Crohn’s and Ulcerative Colitis in a double-blind, placebo-controlled trial, according to a summary of the US federal government website clinicaltrials.gov.

For more information, please contact Paul Armentano, NORML Deputy Director, at paul@norml.org. Full text of the study, “Impact of Cannabis Treatment on the Quality of Life, Weight and Clinical Disease Activity in Inflammatory Bowel Disease Patients: A Pilot Prospective Study,” appears in Digestion.

Prescription Drug Efavirenz Yields False Positive Test Results For THC, Study Says

Pretoria, South Africa: Prescription doses of the antiretroviral prescription drug efavirenz (EFV) cross-reacts in urine immunoassay tests for the carboxy THC metabolite, according to clinical data published online in the journal Annals of Clinical Biochemistry.

Investigators at the University of Pretoria in South Africa analyzed random urine samples from 30 patients on EFV therapy for THC metabolites by two near-testing devices (THC One Step Marijuana and Rapid Response(®) Drugs of Abuse Test Strips) and two automated immunoassays (Roche Diagnostics Cannabinoids II and Beckman Coulter SYNCHRON(®) Systems THC2). THC confirmatory testing was performed by gas chromatography-mass spectrometry (GC-MS).

Authors reported: “GC-MS failed to detect THC metabolites in any of the samples, as did three of the four immunoassays. However, the Rapid Response(®) test strips yielded positive results in 28 out of 30 samples.”

Separate studies have previously documented that efavirenz may yield so-called ‘false positive’ test results for the carboxy THC metabolite on various types of presumptive immunoassay urine tests.

For more information, please contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “Efavirenz interference in urine screening immunoassays for tetrahydrocannabinol,” appears in Annals of Clinical Biochemistry.

Hospice Health Professionals Support Legalization Of Cannabis For Therapeutic Use

Philadelphia, PA: A majority of hospice health professionals favor allowing the legally regulated use of cannabis for terminally ill patients, according to survey data published online in the Journal of Palliative Medicine.

Investigators at the University of Pennsylvania utilized a 16-item questionnaire to assess the knowledge, experience, and views of hospice professionals regarding the use of marijuana in terminally ill patients.

Authors concluded, “The study results revealed that, like the general public, hospice health care providers are generally in favor of legalization of marijuana and, if legalized, would support its use in symptom management for their terminally ill patients.”

Various health professional organizations, including the American Nurses Association and the American Public Health Association, have enacted resolutions in support of allowing patients the legal alternative to use cannabis therapy.

For more information, please contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “Assessment of hospice health professional knowledge, views, and experience with medical marijuana,” appears in the Journal of Palliative Medicine.

NORML and the NORML Foundation: 1600 K Street NW, Mezzanine Level, Washington DC, 20006-2832
Tel: (202) 483-5500 • Fax: (202) 483-0057 • Email: norml@norml.org

TX NORML Sign

Puff, puff, pass...
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • email
  • MySpace
  • Reddit
  • StumbleUpon
  • TwitThis
  • Twitter
  • Tumblr
  • Add to favorites

02

12 2011